These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 24859609

  • 1. The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.
    Pitsikas N, Markou A.
    Neuropharmacology; 2014 Oct; 85():27-35. PubMed ID: 24859609
    [Abstract] [Full Text] [Related]

  • 2. Crocins, the active constituents of Crocus sativus L., counteracted apomorphine-induced performance deficits in the novel object recognition task, but not novel object location task, in rats.
    Pitsikas N, Tarantilis PA.
    Neurosci Lett; 2017 Mar 22; 644():37-42. PubMed ID: 28216334
    [Abstract] [Full Text] [Related]

  • 3. Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.
    Lorrain DS, Baccei CS, Bristow LJ, Anderson JJ, Varney MA.
    Neuroscience; 2003 Mar 22; 117(3):697-706. PubMed ID: 12617973
    [Abstract] [Full Text] [Related]

  • 4. The mGluR2/3 agonist LY379268 reverses NMDA receptor antagonist effects on cortical gamma oscillations and phase coherence, but not working memory impairments, in mice.
    Sokolenko E, Hudson MR, Nithianantharajah J, Jones NC.
    J Psychopharmacol; 2019 Dec 22; 33(12):1588-1599. PubMed ID: 31580222
    [Abstract] [Full Text] [Related]

  • 5. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J, Monn JA, Schoepp DD.
    J Pharmacol Exp Ther; 1999 Oct 22; 291(1):161-70. PubMed ID: 10490900
    [Abstract] [Full Text] [Related]

  • 6. Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats.
    Horiguchi M, Huang M, Meltzer HY.
    Psychopharmacology (Berl); 2011 Sep 22; 217(1):13-24. PubMed ID: 21432027
    [Abstract] [Full Text] [Related]

  • 7. Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge.
    Fell MJ, Katner JS, Johnson BG, Khilevich A, Schkeryantz JM, Perry KW, Svensson KA.
    Neuropharmacology; 2010 Mar 22; 58(3):632-9. PubMed ID: 19951716
    [Abstract] [Full Text] [Related]

  • 8. The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis.
    Fujáková M, Páleníček T, Brunovský M, Gorman I, Tylš F, Kubešová A, Řípová D, Krajča V, Horáček J.
    Pharmacol Biochem Behav; 2014 Jul 22; 122():212-21. PubMed ID: 24631484
    [Abstract] [Full Text] [Related]

  • 9. The novel dehydroepiandrosterone (DHEA) derivative BNN27 counteracts cognitive deficits induced by the D1/D2 dopaminergic receptor agonist apomorphine in rats.
    Pitsikas N, Zoupa E, Gravanis A.
    Psychopharmacology (Berl); 2021 Jan 22; 238(1):227-237. PubMed ID: 33005973
    [Abstract] [Full Text] [Related]

  • 10. Ketamine disrupted storage but not retrieval of information in male rats and apomorphine counteracted its impairing effect.
    Pitsikas N, Carli M.
    Neurosci Lett; 2020 Oct 15; 737():135321. PubMed ID: 32846219
    [Abstract] [Full Text] [Related]

  • 11. Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.
    Lorrain DS, Schaffhauser H, Campbell UC, Baccei CS, Correa LD, Rowe B, Rodriguez DE, Anderson JJ, Varney MA, Pinkerton AB, Vernier JM, Bristow LJ.
    Neuropsychopharmacology; 2003 Sep 15; 28(9):1622-32. PubMed ID: 12825094
    [Abstract] [Full Text] [Related]

  • 12. The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268.
    Imre G.
    CNS Drug Rev; 2007 Sep 15; 13(4):444-64. PubMed ID: 18078428
    [Abstract] [Full Text] [Related]

  • 13. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
    Halberstadt AL, van der Zee JVF, Chatha M, Geyer MA, Powell SB.
    Psychopharmacology (Berl); 2019 Feb 15; 236(2):821-830. PubMed ID: 30448990
    [Abstract] [Full Text] [Related]

  • 14. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
    Galici R, Echemendia NG, Rodriguez AL, Conn PJ.
    J Pharmacol Exp Ther; 2005 Dec 15; 315(3):1181-7. PubMed ID: 16123306
    [Abstract] [Full Text] [Related]

  • 15. Phencyclidine and glutamate agonist LY379268 stimulate dopamine D2High receptors: D2 basis for schizophrenia.
    Seeman P, Guan HC.
    Synapse; 2008 Nov 15; 62(11):819-28. PubMed ID: 18720422
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of metabotropic glutamate (mGlu) 2 receptor and blockade of mGlu1 receptor improve social memory impairment elicited by MK-801 in rats.
    Hikichi H, Kaku A, Karasawa J, Chaki S.
    J Pharmacol Sci; 2013 Nov 15; 122(1):10-6. PubMed ID: 23603933
    [Abstract] [Full Text] [Related]

  • 17. The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat.
    Cartmell J, Perry KW, Salhoff CR, Monn JA, Schoepp DD.
    J Neurochem; 2000 Sep 15; 75(3):1147-54. PubMed ID: 10936197
    [Abstract] [Full Text] [Related]

  • 18. The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat.
    Jones CA, Brown AM, Auer DP, Fone KC.
    Psychopharmacology (Berl); 2011 Mar 15; 214(1):269-83. PubMed ID: 20607219
    [Abstract] [Full Text] [Related]

  • 19. Effects of the mGluR2/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat.
    Imre G, Salomons A, Jongsma M, Fokkema DS, Den Boer JA, Ter Horst GJ.
    Pharmacol Biochem Behav; 2006 Jul 15; 84(3):392-9. PubMed ID: 16857251
    [Abstract] [Full Text] [Related]

  • 20. Effects of the inducible nitric oxide synthase inhibitor aminoguanidine in two different rat models of schizophrenia.
    Lafioniatis A, Orfanidou MA, Papadopoulou ES, Pitsikas N.
    Behav Brain Res; 2016 Aug 01; 309():14-21. PubMed ID: 27132765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.